127 related articles for article (PubMed ID: 25313741)
1. Urachal carcinoma: clinicopathological features, treatment and outcome.
Kumar N; Khosla D; Kumar R; Mandal AK; Saikia UN; Kapoor R; Singh SK; Sharma SC
J Cancer Res Ther; 2014; 10(3):571-4. PubMed ID: 25313741
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of treatment and prognosis in post-operative patients with urachal carcinoma].
Niu HT; Dong P; Wang JN; Huang J; Zeng YX
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1923-5. PubMed ID: 27373362
[TBL] [Abstract][Full Text] [Related]
3. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation.
Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S
Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435
[TBL] [Abstract][Full Text] [Related]
4. [Clinical analysis of 14 cases of urachal carcinoma].
Chen ZF; Wang F; Qin ZK; Dai YP; Zhou FJ; Han H; Liu ZW; Yu SL; Li YH; Ye YL
Ai Zheng; 2008 Sep; 27(9):966-9. PubMed ID: 18799037
[TBL] [Abstract][Full Text] [Related]
5. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
[TBL] [Abstract][Full Text] [Related]
6. Surgical and chemotherapeutic options for urachal carcinoma: report of ten cases and literature review.
Yazawa S; Kikuchi E; Takeda T; Matsumoto K; Miyajima A; Nakagawa K; Oya M
Urol Int; 2012; 88(2):209-14. PubMed ID: 22143067
[TBL] [Abstract][Full Text] [Related]
7. Small cell carcinoma of the urinary bladder. The Mayo Clinic experience.
Choong NW; Quevedo JF; Kaur JS
Cancer; 2005 Mar; 103(6):1172-8. PubMed ID: 15700264
[TBL] [Abstract][Full Text] [Related]
8. Urachal carcinoma: a pathologic and clinical study of 46 cases.
Dhillon J; Liang Y; Kamat AM; Siefker-Radtke A; Dinney CP; Czerniak B; Guo CC
Hum Pathol; 2015 Dec; 46(12):1808-14. PubMed ID: 26364859
[TBL] [Abstract][Full Text] [Related]
9. The clinical epidemiology of urachal carcinoma: results of a large, population based study.
Bruins HM; Visser O; Ploeg M; Hulsbergen-van de Kaa CA; Kiemeney LA; Witjes JA
J Urol; 2012 Oct; 188(4):1102-7. PubMed ID: 22901574
[TBL] [Abstract][Full Text] [Related]
10. Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation.
May M; Helke C; Nitzke T; Vogler H; Hoschke B
Urol Int; 2004; 72(2):103-11. PubMed ID: 14963349
[TBL] [Abstract][Full Text] [Related]
11. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
[TBL] [Abstract][Full Text] [Related]
12. Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.
Boudreaux KJ; Chang SS; Lowrance WT; Rumohr JA; Barocas DA; Cookson MS; Smith JA; Clark PE
Cancer; 2009 Feb; 115(4):770-5. PubMed ID: 19152431
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of Korean patients with clinically localized urachal or non-urachal adenocarcinoma of the bladder.
Cho SY; Moon KC; Park JH; Kwak C; Kim HH; Ku JH
Urol Oncol; 2013 Jan; 31(1):24-31. PubMed ID: 21458312
[TBL] [Abstract][Full Text] [Related]
14. Outcomes in patients with urothelial carcinoma of the bladder with limited pelvic lymph node dissection.
Dhar NB; Campbell SC; Zippe CD; Derweesh IH; Reuther AM; Fergany A; Klein EA
BJU Int; 2006 Dec; 98(6):1172-5. PubMed ID: 16956353
[TBL] [Abstract][Full Text] [Related]
15. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for urachal cancer: a bayesian model-averaging approach.
Kim IK; Lee JY; Kwon JK; Park JJ; Cho KS; Ham WS; Hong SJ; Yang SC; Choi YD
Korean J Urol; 2014 Sep; 55(9):574-80. PubMed ID: 25237458
[TBL] [Abstract][Full Text] [Related]
17. [Radical cystectomy for superficial tumors in the BCG era].
Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
[TBL] [Abstract][Full Text] [Related]
18. Long-term survival after combined modality treatment in metastatic bladder cancer patients presenting with supra-regional tumor positive lymph nodes only.
de Vries RR; Nieuwenhuijzen JA; Meinhardt W; Bais EM; Horenblas S
Eur J Surg Oncol; 2009 Apr; 35(4):352-5. PubMed ID: 18722076
[TBL] [Abstract][Full Text] [Related]
19. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
